Studies

CellWell record HH-538816

Lentinan inhibits breast cancer cell growth through the dual downregulation of tumor-promoting effectors CD133 and SCGB2A2

Wang J; Cheng H; Mu X; Liu Y; Huang L; Wu N; Zhan Y; Zhang Y; Wang J; Wang K

International journal of biological macromolecules ยท 2026

In plain language

Water-extracted Lentinus edodes polysaccharide suppressed breast cancer growth in vitro and in vivo by downregulating CD133 and SCGB2A2 expression, where it competitively binds CD133 to block its interaction with SCGB2A2.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-538816

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.